No longer the stuff of fantasy, AI is entering the real world everywhere—biotech included. AI’s biotech applications include drug target identification, drug screening, and the analysis of ...
Never before, scientists say, have so many of the world’s researchers focused so urgently on a single topic. Nearly all other research has ground to a halt.
As gene-based vaccines are being designed and tested at unprecedented speeds to fight COVID-19, scientists wonder if this will be the technology’s make-or-break moment.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 31, 2020.
The following is a roundup of some of this week's non-coronavirus biopharma news.
The coronavirus has killed more than 4,000 people in the United States so far, and the race is on to find a vaccine, along with other treatments, to save the lives of those who are already ...
There are significant global efforts underway to diagnose, treat and prevent infections from the virus. Pharmaceutical companies are working globally to combat COVID-19.
The biotech industry has outperformed in past downturns. Here are JPMorgan's top choices to invest in now.